Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Alterations in outer membrane proteins of Pseudomonas aeruginosa associated with selective resistance to quinolones.

Literature DB >> 3134852

Alterations in outer membrane proteins of Pseudomonas aeruginosa associated with selective resistance to quinolones.

Abstract

Electrophoresis of outer membrane proteins in three ciprofloxacin-resistant strains of Pseudomonas aeruginosa isolated during therapy and their in vitro revertants indicated that diminution or loss of a 31- to 32-kilodalton outer membrane protein correlated with resistance in two of the three isolates. Resistance was unstable and caused no cross-resistance with other antibiotics.

Entities: Chemical Species

Mesh：

Substances：

Year: 1988 PMID： 3134852 PMCID： PMC172277 DOI： 10.1128/AAC.32.5.785

Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN： 0066-4804 Impact factor: 5.191

13 in total

1. Outer membranes of gram-negative bacteria. XIX. Isolation from Pseudomonas aeruginosa PAO1 and use in reconstitution and definition of the permeability barrier.

Authors: R E Hancock; H Nikaido
Journal: J Bacteriol Date: 1978-10 Impact factor: 3.490

2. Some properties of subunits of DNA gyrase from Pseudomonas aeruginosa PAO1 and its nalidixic acid-resistant mutant.

Authors: Y Inoue; K Sato; T Fujii; K Hirai; M Inoue; S Iyobe; S Mitsuhashi
Journal: J Bacteriol Date: 1987-05 Impact factor: 3.490

3. Cross-resistance to nalidixic acid, trimethoprim, and chloramphenicol associated with alterations in outer membrane proteins of Klebsiella, Enterobacter, and Serratia.

Authors: L Gutmann; R Williamson; N Moreau; M D Kitzis; E Collatz; J F Acar; F W Goldstein
Journal: J Infect Dis Date: 1985-03 Impact factor: 5.226

4. Emergence of resistance to beta-lactams, aminoglycosides, and quinolones during combination therapy for infection due to Serratia marcescens.

Authors: C C Sanders; C Watanakunakorn
Journal: J Infect Dis Date: 1986-03 Impact factor: 5.226

Review 5. Mechanisms of action of and resistance to ciprofloxacin.

Authors: D C Hooper; J S Wolfson; E Y Ng; M N Swartz
Journal: Am J Med Date: 1987-04-27 Impact factor: 4.965

6. Genetic and biochemical characterization of norfloxacin resistance in Escherichia coli.

Authors: D C Hooper; J S Wolfson; K S Souza; C Tung; G L McHugh; M N Swartz
Journal: Antimicrob Agents Chemother Date: 1986-04 Impact factor: 5.191

7. Resistance of Pseudomonas aeruginosa PAO to nalidixic acid and low levels of beta-lactam antibiotics: mapping of chromosomal genes.

Authors: M Rella; D Haas
Journal: Antimicrob Agents Chemother Date: 1982-08 Impact factor: 5.191

8. Plasmid-mediated resistance to nalidixic acid in Shigella dysenteriae type 1.

Authors: M H Munshi; D A Sack; K Haider; Z U Ahmed; M M Rahaman; M G Morshed
Journal: Lancet Date: 1987-08-22 Impact factor: 79.321

9. Selection of multiple antibiotic resistance by quinolones, beta-lactams, and aminoglycosides with special reference to cross-resistance between unrelated drug classes.

Authors: C C Sanders; W E Sanders; R V Goering; V Werner
Journal: Antimicrob Agents Chemother Date: 1984-12 Impact factor: 5.191

10. Comparative evaluation of recently developed quinolone compounds--with a note on the frequency of resistant mutants.

Authors: W Cullmann; M Stieglitz; B Baars; W Opferkuch
Journal: Chemotherapy Date: 1985 Impact factor: 2.544

28 in total

Review 1. Quinolone antimicrobial agents: adverse effects and bacterial resistance.

Authors: J S Wolfson
Journal: Eur J Clin Microbiol Infect Dis Date: 1989-12 Impact factor: 3.267

2. A pleiotropic, posttherapy, enoxacin-resistant mutant of Pseudomonas aeruginosa.

Authors: L J Piddock; M C Hall; F Bellido; M Bains; R E Hancock
Journal: Antimicrob Agents Chemother Date: 1992-05 Impact factor: 5.191

3. In vitro activity of tosufloxacin, a new quinolone, against respiratory pathogens derived from cystic fibrosis sputum.

Authors: A G Arguedas; J C Akaniro; H R Stutman; M I Marks
Journal: Antimicrob Agents Chemother Date: 1990-11 Impact factor: 5.191

4. Resistance to pefloxacin in Pseudomonas aeruginosa.

Authors: M Michea-Hamzehpour; C Lucain; J C Pechere
Journal: Antimicrob Agents Chemother Date: 1991-03 Impact factor: 5.191

5. Persistence mechanisms in Pseudomonas aeruginosa from cystic fibrosis patients undergoing ciprofloxacin therapy.

Authors: J M Diver; T Schollaardt; H R Rabin; C Thorson; L E Bryan
Journal: Antimicrob Agents Chemother Date: 1991-08 Impact factor: 5.191

6. Inhibitory effects of ciprofloxacin and sparfloxacin on DNA gyrase purified from fluoroquinolone-resistant strains of methicillin-resistant Staphylococcus aureus.

Authors: J Okuda; S Okamoto; M Takahata; T Nishino
Journal: Antimicrob Agents Chemother Date: 1991-11 Impact factor: 5.191

Review 7. Mechanisms of resistance to quinolones.

Authors: E Cambau; L Gutmann
Journal: Drugs Date: 1993 Impact factor: 9.546

8. Pseudomonas aeruginosa fur overlaps with a gene encoding a novel outer membrane lipoprotein, OmlA.

Authors: U A Ochsner; A I Vasil; Z Johnson; M L Vasil
Journal: J Bacteriol Date: 1999-02 Impact factor: 3.490

9. Fluoroquinolone supersusceptibility mediated by outer membrane protein OprH overexpression in Pseudomonas aeruginosa: evidence for involvement of a nonporin pathway.

Authors: M Young; R E Hancock
Journal: Antimicrob Agents Chemother Date: 1992-11 Impact factor: 5.191

10. Dose ranging and fractionation of intravenous ciprofloxacin against Pseudomonas aeruginosa and Staphylococcus aureus in an in vitro model of infection.

Authors: C R Marchbanks; J R McKiel; D H Gilbert; N J Robillard; B Painter; S H Zinner; M N Dudley
Journal: Antimicrob Agents Chemother Date: 1993-09 Impact factor: 5.191